<DOC>
	<DOCNO>NCT01132196</DOCNO>
	<brief_summary>The purpose study assess bioavailability Divalproex Sodium DR Tablets 500 mg versus Depakote DR 500 mg tablet washout period 10 day healthy subject .</brief_summary>
	<brief_title>Bioequivalence Study Divalproex Sodium DR Tablets 500 mg Dr. Reddy 's Under Fed Conditions</brief_title>
	<detailed_description>An open label , balance , randomize , two-treatment , two-period , two-sequence , single dose , crossover , bioequivalence study Divalproex sodium DR 500 mg tablet Dr.Reddy 's Laboratories Limited , Generics , India compare DepakoteÂ® DR ( contain Divalproex sodium ) 500 mg tablet Abbott Laboratories PR Ltd. , Barceloneta , PR , healthy , adult , human subject feed condition .</detailed_description>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Subjects must fulfill follow criterion consider inclusion study : Subjects provide write informed consent . Subjects must healthy , adult , human being within 1845 year age ( inclusive ) weigh least 50 kg . Having Body Mass Index ( BMI ) 18.5 24.9 ( inclusive ) , calculate weight Kg/height m2 Subjects must normal health determine medical history physical examination perform within 21 day prior commencement study . Subjects whose screen laboratory value within normal limit consider physician/investigator clinical significance . Availability subject entire study period willingness adhere protocol requirement evidence write informed consent . The subject exclude base follow criterion screen study Subjects incapable understanding informed consent . Subjects : Systolic blood pressure le 90 mm Hg 140 mm Hg Diastolic blood pressure le 60 mm Hg 94 mm Hg . Minor deviation ( 24 mm Hg ) checkin may acceptable discretion physician/investigator . Pulse rate 50/min 100/min . History hypersensitivity idiosyncratic reaction Divalproex sodium relate drug . Any evidence impairment renal , hepatic , cardiac , lung gastrointestinal function . Consumption grapefruit past ten day prior dose day completion study . Regular smoker habit smoke nine cigarette per day difficulty abstain smoke 48 hour dose sample period Subjects take counter prescribed medication enzyme modify systemic medication last 7 30 day respectively dose . Subjects participate clinical investigation use experimental drug/donated blood past 90 day date start study . Subjects clinically significant abnormality ( Laboratory Findings , ECG , XRay , Drugs abuse , Alcohol etc. , ) and/or significant disease ( HIV , HCV , Syphilis , Hepatitis B etc. , ) . Female subject pregnant able ( woman child bear potential ) become pregnant study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Crossover</keyword>
	<keyword>Divalproex Sodium</keyword>
</DOC>